Data on naptumomab estafenatox enhancing CAR-T cells potency presented by Active Biotech's partner NeoTX at SITC 2021
Lund, Sweden - November 30, 2021 - Active Biotech and its partner NeoTX announced that the preclinical data on naptumomab enhancing the potency of CAR-T cells was presented on Nov 12th at the Society for
United States Hans Kolam Society For Immunotherapy Of Cancer Waltere Washington Convention Center Biotech To Neotx Therapeutics Ltd Annual Meeting
Source: finanznachrichten.de